BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35074437)

  • 1. E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers.
    Chang SC; Zhang BX; Ding JL
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188679. PubMed ID: 35074437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
    Ullah K; Zubia E; Narayan M; Yang J; Xu G
    FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Characterization of Physiological Pairing of E2 Ubiquitin-Conjugating Enzymes and E3 Ubiquitin Ligases.
    Brillada C; Trujillo M
    Methods Mol Biol; 2023; 2581():13-29. PubMed ID: 36413307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.
    Chen S; Yang J; Zhang Y; Duan C; Liu Q; Huang Z; Xu Y; Zhou L; Xu G
    J Biol Chem; 2018 Jul; 293(29):11296-11309. PubMed ID: 29871923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-tiered pairing selectivity between E2 ubiquitin-conjugating enzymes and E3 ligases.
    Turek I; Tischer N; Lassig R; Trujillo M
    J Biol Chem; 2018 Oct; 293(42):16324-16336. PubMed ID: 30185618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.
    Hormaechea-Agulla D; Kim Y; Song MS; Song SJ
    Mol Cells; 2018 Mar; 41(3):168-178. PubMed ID: 29562734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite Split-GFP for High Throughput Screening of Small Molecules: A Powerful Strategy for Targeting Transient/Labile Interactors like E2-E3 Ubiquitination Enzymes.
    Polge C; Cabantous S; Taillandier D
    Chembiochem; 2024 Mar; 25(6):e202300723. PubMed ID: 38088048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Survey on the Expression of the Ubiquitin Proteasome System Components HECT- and RBR-E3 Ubiquitin Ligases and E2 Ubiquitin-Conjugating and E1 Ubiquitin-Activating Enzymes during Human Brain Development.
    Magnati S; Alladio E; Bracco E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro autoubiquitination activity of E3 ubiquitin ligases of the N-degron pathway.
    Sandmann A; Dissmeyer N
    Methods Enzymol; 2023; 686():205-220. PubMed ID: 37532400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and interaction modes of 40 rice E2 ubiquitin-conjugating enzymes with 17 rice ARM-U-box E3 ubiquitin ligases.
    Bae H; Kim WT
    Biochem Biophys Res Commun; 2014 Feb; 444(4):575-80. PubMed ID: 24486490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
    Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
    Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein-Protein Interaction Inhibitors.
    Weber E; Rothenaigner I; Brandner S; Hadian K; Schorpp K
    SLAS Discov; 2017 Mar; 22(3):316-323. PubMed ID: 27909234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy.
    Di Gregorio J; Appignani M; Flati V
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of generic versus specific E2-RING E3 interactions in protein ubiquitination.
    Gundogdu M; Walden H
    Protein Sci; 2019 Oct; 28(10):1758-1770. PubMed ID: 31340062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ubiquitin Conjugating Enzyme: An Important Ubiquitin Transfer Platform in Ubiquitin-Proteasome System.
    Liu W; Tang X; Qi X; Fu X; Ghimire S; Ma R; Li S; Zhang N; Si H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of ubiquitin E2 enzymes is determined jointly by the U-box domains and substrates of E3 ligases.
    Jin B; Li B; Qu J; Sun Y; Wang M; Yang C; Fan Y; Wang Y; Xu P; Sun H; Jiang B; Zhao B
    FEBS Lett; 2024 Mar; 598(6):702-715. PubMed ID: 38439679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.